Cyclic peptides as ADAM protease inhibitors

Research output: Patent


The invention relates to a method for inhibiting an ADAM protease, comprising inhibiting binding to an integrin-binding loop of a disintegrin domain in the ADAM protease. Also provided are cyclic peptides which inhibit binding to an integrin-binding loop of an ADAM protease, as well as associated pharmaceutical compositions, uses and methods of treatment.
Type: Grant
Original languageEnglish
Patent number9546198
Priority date14/06/2015
Publication statusPublished - 17 Jan 2017


Dive into the research topics of 'Cyclic peptides as ADAM protease inhibitors'. Together they form a unique fingerprint.

Cite this